Treatment Preferences of Neurologists in Generalized Myasthenia Gravis: A Conjoint Analysis Study
Neurologists treating gMG placed the highest value on rapid and clinically meaningful symptom improvement, consistent with the therapeutic goals of emerging targeted therapies. However, substantial heterogeneity in preferences, especially regarding administration burden, emphasizes the need for individualized approaches and shared decision-making.
Authors
- Elena Cortés‐Vicente (ORCID: https://orcid.org/0000-0002-1428-1072)
- Gerardo Gutiérrez‐Gutiérrez (ORCID: https://orcid.org/0000-0003-1391-754X)
- Paola Díaz-Abós (ORCID: https://orcid.org/0000-0002-7097-0665)
- Luís Querol (ORCID: https://orcid.org/0000-0002-4289-8264)
- Neus Canal
- Rocío Gómez-Ballesteros (ORCID: https://orcid.org/0000-0001-9582-9230)
- Pablo Rebollo (ORCID: https://orcid.org/0000-0002-7517-6540)
- Ramón Villaverde (ORCID: https://orcid.org/0000-0002-0064-8910)
- Ana Núñez Ares
- Virginia Reyes
- Thaís Armangué (ORCID: https://orcid.org/0000-0001-6192-6171)
- Jorge Mauriño (ORCID: https://orcid.org/0000-0001-9858-3555)
- Mònica Sarmiento (ORCID: https://orcid.org/0000-0002-3109-3161)
- Elisa Salas
Institutions
- Hospital Sant Joan de Déu Barcelona (ES)
- Hospital de Sant Pau (ES)
- Hospital General Universitario Morales Meseguer (ES)
- Instituto Químico Biológico (ES)
- Hospital Regional Universitario de Málaga (ES)
- Roche (Spain) (ES)
- Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)
- Hospital Universitario Infanta Sofía (ES)
- Complejo Asistencial Universitario de Palencia (ES)
Publication Details
- Journal
- Neurology and Therapy
- Published
- 2025-09-19
- DOI
- https://doi.org/10.1007/s40120-025-00821-y
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 0.00